Clear Search

Books+ Search Results

Subject with Hierarchy: Is
Is Is Not
Drugs > Safety regulations

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (33)
1.
The multidimensional landscape of pharmacovigilance part 2, development and management
Author
Hagemann, Ulrich
Published
London : Henry Stewart Talks, 2023.
Online
Streaming video
Location
Yale Internet Resource >> None
Format
Images / Online / Video & Film
2.
A structured approach for pharmaceutical pre-marketing safety surveillance
Author
Tremmel, Lothar
Published
London : Henry Stewart Talks, 2021.
Online
Streaming video
Location
Yale Internet Resource >> None
Format
Images / Online / Video & Film
3.
Stronger food and drug regulatory systems abroad
Author
National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Stronger Food and Drug Regulatory Systems Abroad, author
Published
Washington, DC : National Academies Press, [2020]
©2020.
Location
Law Library >> RA601 .N38 2020
Format
Books
4.
Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization
Author
Thaul, Susan
Published
[Washington, D.C.] : Congressional Research Service, 2018-
Online
https://purl.fdlp.gov/GPO/gpo122740
Location
Yale Internet Resource >> None
Format
Online
5.
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
https://purl.fdlp.gov/GPO/gpo93483
Location
Yale Internet Resource >> None
Format
Books / Online
6.
Antitrust concerns and the FDA approval process : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:115-27
Format
Books
7.
Drug safety, FDA has improved its foreign drug inspection program, but needs to assess the effectiveness and staffing of its foreign offices : report to the Committee on Energy and Commerce
Author
United States. Government Accountability Office, author
Published
[Washington, D.C.] : United States Government Accountability Office, 2016.
Online
http://purl.fdlp.gov/GPO/gpo76780
Location
Yale Internet Resource >> None
Format
Books / Online
8.
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2016.
Online
http://purl.fdlp.gov/GPO/gpo66684
Location
Yale Internet Resource >> None
Format
Books / Online
9.
Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2016.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-132
Format
Books
10.
Food and drug safety, public health, and the environment in China : hearing before the Congressional-Executive Commission on China, one hundred thirteenth congress, first session, May 22, 2013
Author
United States. Congressional-Executive Commission on China, author
Published
Washington : U.S. Government Printing Office, 2013.
Online
PDF version
Text version
Location
Yale Internet Resource
Format
Books / Online
11.
Food and drug safety, public health, and the environment in China : hearing before the Congressional-Executive Commission on China, one hundred thirteenth congress, first session, May 22, 2013
Author
United States. Congressional-Executive Commission on China, author
Published
Washington : U.S. Government Printing Office, 2013.
Washington, D.C. : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 44:F 68
Format
Books
12.
Food and drug safety, public health, and the environment in China : hearing before the Congressional-Executive Commission on China, one hundred thirteenth congress, first session, May 22, 2013
Author
United States. Congressional-Executive Commission on China, author
Published
Washington : U.S. Government Printing Office, 2013.
Online
PDF version:
Text version:
Location
Yale Internet Resource >> None
Format
Books / Online
13.
Health : drugs and medical devices : agreement between the United States of America and China, signed at Beijing, December 11, 2007
Author
United States, author
Published
[Washington, D.C.] : U.S. Dept. of State, [2013?]
Online
https://purl.fdlp.gov/GPO/gpo36435
Location
Yale Internet Resource
Format
Books / Online
14.
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health author
Published
Washington : U.S. Government Printing Office, 2012.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:111-103
Format
Books
15.
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2012.
Online
http://purl.fdlp.gov/GPO/gpo33795
Location
Yale Internet Resource >> None
Format
Books / Online
16.
The dawn of drug safety : the discovery, reporting and management of adverse drug reactions prior to and including the Thalidomide disaster
Author
Stephens, M. D. B., 1930-
Published
Easton, Winchester, Hampshire : George Mann, c2010.
Location
SML, Stacks, LC Classification >> RM301 .S746 2010 (LC)
Format
Books
17.
Corrupt to the core : memoirs of a Health Canada whistleblower
Author
Chopra, Shiv
Published
Caledon, Ont. : Kos Publishing, c2009.
Online
Table of contents only
Location
SML, Stacks, LC Classification >> RA401.C3 C46X 2009 (LC) Oversize
Format
Books
18.
Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2009.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.110-828
Format
Books
19.
Restoring FDA's ability to keep America's families safe hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O., 2009.
Online
Text version:
PDF version:
Location
Yale Internet Resource >> None
Format
Books / Online
20.
Restoring FDA's ability to keep America's families safe hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2009.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
21.
Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, second session, on examining the U.S. Food and Drug Administration, focusing on its ability to ensure the safety of food and the drug supply in the United States, April 24, 2008
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2009.
Online
4.L 11/4:S.HRG.110-828
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
22.
Post-market surveillance of pharmaceuticals : report of the Standing Committee on Health
Author
Canada. Parliament. House of Commons. Standing Committee on Health
Published
[Ottawa] : Standing Committee on Health, 2008.
Location
Library Shelving Facility (LSF) >> XC62-392/1-1-04
Format
Books
23.
Science and mission at risk : FDA's self-assessment : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, January 29, 2008
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Printing Office, 2008.
Online
https://purl.fdlp.gov/GPO/gpo88827
Location
Yale Internet Resource >> None
Format
Books / Online
24.
Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.109-850
Format
Books
25.
Building a 21st century FDA proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
26.
Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
Online
4.L 11/4:S.HRG.109-850
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
27.
Ensuring drug safety where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
28.
Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.109-75
Format
Books
29.
Ensuring drug safety : where do we go from here? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., [Congressional Sales Office], 2005.
Online
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
30.
Risk and responsibility : the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
Author
United States. Congress. House. Committee on Government Reform
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Online
4.G 74/7:R 49/3/ ERRATA
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
31.
Risk and responsibility the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
Author
United States. Congress. House. Committee on Government Reform
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
32.
Risk and responsibility : the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
Author
United States. Congress. House. Committee on Government Reform
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Online
http://purl.access.gpo.gov/GPO/LPS63169
Errata:
Location
Library Shelving Facility (LSF) >> Y 4.G 74/7:R 49/3 +/Errata
Format
Books
33.
Risk and responsibility : the roles of FDA and pharmaceutical companies in ensuring the safety of approved drugs, like Vioxx : hearing before the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, first session, May 5, 2005
Author
United States. Congress. House. Committee on Government Reform
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Online
Online book
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
34.
Getting your drug approved : FDA's own guidances
Published
Falls Church, Va. : Washington Business Information, c2002-2003.
Location
Library Shelving Facility (LSF) >> Ref 14 RM301.27 G47 + Oversize
Format
Books
35.
Drug safety most drugs withdrawn in recent years had greater health risks for women
Author
United States. General Accounting Office
Published
Washington, D.C. : The Office, [2001]
Online
Search for full text online
Location
Yale Internet Resource >> None
Format
Books / Online
36.
Drug safety : most drugs withdrawn in recent years had greater health risks for women
Author
United States. General Accounting Office
Published
Washington, D.C. : The Office, [2001]
Online
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
37.
Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 2000.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.106-651
Format
Books
38.
Drug safety and pricing : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 2000.
Online
4.L 11/4:S.HRG.106-651
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
39.
Drug safety and pricing hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., 2000.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
40.
Getting your drug approved: FDA's own guidelines
Published
Falls Church, Va. : Washington Business Information, c2000.
Location
Library Shelving Facility (LSF) >> S Ref 14 RM301.27 G47 2000 + Oversize
Format
Books
41.
Regulating medicines in Europe : competition, expertise, and public health
Author
Abraham, John, 1961-
Published
London ; New York : Routledge, 2000.
Location
Law Library >> RM301.27 .A273 2000
Format
Books
42.
Regulating medicines in Europe : competition, expertise, and public health
Author
Abraham, John, 1961-
Published
London ; New York : Routledge , 2000.
Location
MEDICAL >> RM301.27 A273 2000
Format
Books
43.
Drug regulation : Colombia, Mexico
Published
[Washington, D.C.] : The Law Library of Congress, Global Legal Research Directorate, 1997.
Online
https://purl.fdlp.gov/GPO/gpo195637
Location
Yale Internet Resource
Format
Books / Online
44.
International regulation of preparation, distribution and import/export of drugs : Colombia, Mexico
Published
[Washington, D.C.] : The Law Library of Congress, Global Legal Research Directorate, 1997.
Online
https://purl.fdlp.gov/GPO/gpo195639
Location
Yale Internet Resource
Format
Books / Online
45.
FDA premarket approval : process of approving Ansaid as a drug : GAO report to Congressional requesters
Published
Washington, D.C. : The Office, [1992]
Online
1992 Apr
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
46.
FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow report to the Congress
Author
United States. General Accounting Office
Published
Washington, D.C. : U.S. General Accounting Office, [1982]
Online
Search for full text online
Location
Yale Internet Resource >> None
Format
Books / Online
47.
FDA's approach to reviewing over-the-counter drugs is reasonable, but progress is slow : report to the Congress
Author
United States. General Accounting Office
Published
Washington, D.C. : U.S. General Accounting Office, [1982]
Online
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
48.
The protection of human life
Published
[Washington, D.C.] : Food and Drug Administration, U.S. Dept. of Healthe, Education, and Welfare, [1967?]
Online
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
49.
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Online
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online
50.
Food and drug safety, public health, and the environment in China : hearing before the Congressional-Executive Commission on China, one hundred thirteenth congress, first session, May 22, 2013
Author
United States. Congressional-Executive Commission on China
Online
Online book
Location
HathiTrust Digital Library >> Online Resource
Format
Books / Online